KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Goodwill (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Goodwill for 7 consecutive years, with $800000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Goodwill changed 0.0% year-over-year to $800000.0, compared with a TTM value of $800000.0 through Jun 2025, changed 0.0%, and an annual FY2022 reading of $800000.0, changed N/A over the prior year.
  • Goodwill was $800000.0 for Q2 2025 at Travere Therapeutics, roughly flat from $800000.0 in the prior quarter.
  • Across five years, Goodwill topped out at $900000.0 in Q1 2022 and bottomed at $800000.0 in Q4 2022.
  • Average Goodwill over 3 years is $820000.0, with a median of $800000.0 recorded in 2022.
  • Peak annual rise in Goodwill hit 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
  • Year by year, Goodwill stood at $800000.0 in 2022, then changed by 0.0% to $800000.0 in 2024, then changed by 0.0% to $800000.0 in 2025.
  • Business Quant data shows Goodwill for TVTX at $800000.0 in Q2 2025, $800000.0 in Q1 2025, and $800000.0 in Q2 2024.